Corvus Capital https://corvuscapital.com/ Mon, 19 Feb 2024 14:56:01 +0000 en-GB hourly 1 https://wordpress.org/?v=6.6.1 Manoira Corporation https://corvuscapital.com/portfolio/manoira/?utm_source=rss&utm_medium=rss&utm_campaign=manoira https://corvuscapital.com/portfolio/manoira/#respond Mon, 15 Jan 2024 16:25:02 +0000 https://corvuscapital.com/?p=312 Corvus is the founding and majority shareholder of Manoira Corporation, a specialty animal treatment company focused on developing proprietary intellectual property using solid form technology. Manoira specialise in the research and development of pharmaceutical and other health products for livestock and pets and intend to develop their portfolio of products to prevent and treat a variety of animal diseases and conditions.

The post Manoira Corporation appeared first on Corvus Capital.

]]> Corvus is the founding and majority shareholder of Manoira Corporation, a specialty animal treatment company focused on developing proprietary intellectual property using solid form technology. Manoira specialise in the research and development of pharmaceutical and other health products for livestock and pets and intend to develop their portfolio of products to prevent and treat a variety of animal diseases and conditions.

The post Manoira Corporation appeared first on Corvus Capital.

]]> https://corvuscapital.com/portfolio/manoira/feed/ 0 Conduit Pharmaceuticals https://corvuscapital.com/portfolio/www-conduitpharma-com/?utm_source=rss&utm_medium=rss&utm_campaign=www-conduitpharma-com https://corvuscapital.com/portfolio/www-conduitpharma-com/#respond Tue, 18 Apr 2023 12:54:27 +0000 https://corvuscapital.com/?p=287 Corvus is the founding and majority shareholder of Conduit Pharmaceuticals, a disease agnostic life science company providing an efficient model for compound development. Conduit successfully completed a business combination with Murphy Canyon Acquisition Corp. in September 2023 for a proforma enterprise value of approximately $720 MM.

(Nasdaq: CDT)

The post Conduit Pharmaceuticals appeared first on Corvus Capital.

]]> Corvus is the founding and majority shareholder of Conduit Pharmaceuticals, a disease agnostic life science company providing an efficient model for compound development. Formed in 2019, Conduit is a departure from the traditional big pharma/biotech business model whereby, typically companies shepherd their assets through regulatory approval, Conduit acquires assets that are Phase II-ready and then seeks an exit through third-party license deals following successful clinical trials. Conduit successfully completed a business combination with Murphy Canyon Acquisition Corp. (Nasdaq: MURF) in September 2023 for a proforma enterprise value of approximately $720 MM.

(Nasdaq: CDT)

www.conduitpharma.com

The post Conduit Pharmaceuticals appeared first on Corvus Capital.

]]> https://corvuscapital.com/portfolio/www-conduitpharma-com/feed/ 0 East Imperial Plc https://corvuscapital.com/portfolio/east-imperial-plc/?utm_source=rss&utm_medium=rss&utm_campaign=east-imperial-plc https://corvuscapital.com/portfolio/east-imperial-plc/#respond Mon, 31 Jan 2022 15:27:51 +0000 http://corvuscapital.com/?p=144 Corvus Capital is pleased to have advised Taylor Partners, the activist shareholder of East Imperial plc (LON: EISB), alongside Strand Hanson, on Taylor Partner's successful proposition to make a number of Board changes at EISB.

The post East Imperial Plc appeared first on Corvus Capital.

]]> Corvus Capital is pleased to have advised Taylor Partners, the activist shareholder of East Imperial plc (LON: EISB), alongside Strand Hanson, on Taylor Partner’s successful proposition to make a number of Board changes at EISB, in order to professionalise and improve corporate governance standards at the Company as they seek to execute their growth strategy. The changes were made only after Taylor Partners convened a hostile General Meeting, announced its concerns and intentions to the market, and garnered significant support from shareholders of the Company for its actions, along with formal Letters of Intent with regard to voting at the General Meeting.
Mark Taylor, Taylor Partners: “Corvus’ knowledge of the London Market, Listing Rules and UK Takeover Code enabled us to deliver the required board changes, ultimately without the need for a contested General Meeting, in order to best position East Imperial for future growth.”
Dr Andrew Regan, Chief Executive Officer, Corvus Capital: “We are pleased to have advised Taylor Partners on its successful proposition to make Board changes at East Imperial. We look forward to supporting the company as they seek to execute the growth strategy.”

www.eastimperial.co.uk

The post East Imperial Plc appeared first on Corvus Capital.

]]> https://corvuscapital.com/portfolio/east-imperial-plc/feed/ 0 Ebers Tech Inc. https://corvuscapital.com/portfolio/ebers-tech-inc/?utm_source=rss&utm_medium=rss&utm_campaign=ebers-tech-inc https://corvuscapital.com/portfolio/ebers-tech-inc/#respond Wed, 27 Apr 2022 12:56:02 +0000 http://corvuscapital.com/?p=250 Corvus is the founding shareholder of Ebers Tech Inc., a private Canadian pharmaceutical company that utilises Co-crystallization and other technology to generate and monetize unique patented compounds and Intellectual Property around cannabinoids and psychedelics.

The post Ebers Tech Inc. appeared first on Corvus Capital.

]]> Corvus is the founding shareholder of Ebers Tech Inc., a private Canadian pharmaceutical company that utilises Co-crystallization and other technology to generate and monetize unique patented compounds and Intellectual Property around cannabinoids and psychedelics for pharmaceutical application and development.

www.ebers.ca

The post Ebers Tech Inc. appeared first on Corvus Capital.

]]> https://corvuscapital.com/portfolio/ebers-tech-inc/feed/ 0 Nuformix https://corvuscapital.com/portfolio/nuformix-2/?utm_source=rss&utm_medium=rss&utm_campaign=nuformix-2 https://corvuscapital.com/portfolio/nuformix-2/#respond Wed, 26 Jun 2019 17:08:39 +0000 http://corvuscapital.com/?p=134 Corvus originated and negotiated Nuformix’s successful listing on the London Stock Exchange, by way of a Reverse Takeover by Levrett Plc, delivering 120x return for original investors.

The post Nuformix appeared first on Corvus Capital.

]]> Corvus originated and negotiated Nuformix’s successful listing on the London Stock Exchange, by way of a Reverse Takeover by Levrett Plc, delivering 120x return for original investors.

The post Nuformix appeared first on Corvus Capital.

]]> https://corvuscapital.com/portfolio/nuformix-2/feed/ 0 Protected: Nuformix https://corvuscapital.com/portfolio/nuformix/?utm_source=rss&utm_medium=rss&utm_campaign=nuformix https://corvuscapital.com/portfolio/nuformix/#respond Thu, 18 Aug 2016 12:44:45 +0000 http://localhost/corvus/?p=117 There is no excerpt because this is a protected post.

The post Protected: Nuformix appeared first on Corvus Capital.

]]>

This content is password protected. To view it please enter your password below:

The post Protected: Nuformix appeared first on Corvus Capital.

]]> https://corvuscapital.com/portfolio/nuformix/feed/ 0 ASOS Plc https://corvuscapital.com/portfolio/asos-plc/?utm_source=rss&utm_medium=rss&utm_campaign=asos-plc https://corvuscapital.com/portfolio/asos-plc/#respond Fri, 05 Aug 2016 11:31:51 +0000 http://corvus-team-applewatch.com.dev/?p=66 Corvus Capital was one of the founding shareholders in ASOS Plc. now the UK’s largest independent online fashion and beauty retailer.

The post ASOS Plc appeared first on Corvus Capital.

]]> Corvus Capital was one of the founding shareholders in ASOS Plc. now the UK’s largest independent online fashion and beauty retailer. The company was established in June 2000 and admitted to AIM in October 2001 with a market capitalisation of £12 million, which now has now risen to over £3.5 billion.

The post ASOS Plc appeared first on Corvus Capital.

]]> https://corvuscapital.com/portfolio/asos-plc/feed/ 0 Cloudtag® https://corvuscapital.com/portfolio/cloudtag/?utm_source=rss&utm_medium=rss&utm_campaign=cloudtag https://corvuscapital.com/portfolio/cloudtag/#respond Fri, 05 Aug 2016 11:13:27 +0000 http://corvus-team-applewatch.com.dev/?p=42 Corvus was the founding shareholder & principal provider of capital to AIM listed CloudTag.

The post Cloudtag® appeared first on Corvus Capital.

]]> CloudTag® brings together world leaders in nano-electronics, medical technology, exercise science and software development to bring a unique and relevant product to the weight loss and fitness markets. With years of experience CloudTag® recognises the barriers to prolonged success in losing weight and aims to empower the user with a solution to fit around their lifestyle and surroundings, becoming the dashboard for health, fitness and nutrition.

The post Cloudtag® appeared first on Corvus Capital.

]]> https://corvuscapital.com/portfolio/cloudtag/feed/ 0 Lodore Resources https://corvuscapital.com/portfolio/lodore-resources-plc/?utm_source=rss&utm_medium=rss&utm_campaign=lodore-resources-plc https://corvuscapital.com/portfolio/lodore-resources-plc/#respond Fri, 05 Aug 2016 11:29:34 +0000 http://corvus-team-applewatch.com.dev/?p=62 Corvus was a founding shareholder and structured the initial finance for the flotation of Lodore Resources plc.

The post Lodore Resources appeared first on Corvus Capital.

]]> Corvus was a founding shareholder and structured the initial finance for the flotation of Lodore Resources plc, an investment company whose primary objective was to build a group specialising in the oil and gas sector. Lodore listed onto AIM in 2004 with a market capitalisation of £6.4 million. The company was acquired in 2005 for a total consideration of £115.0 million.

The post Lodore Resources appeared first on Corvus Capital.

]]> https://corvuscapital.com/portfolio/lodore-resources-plc/feed/ 0 Imperial Energy https://corvuscapital.com/portfolio/imperial-energy/?utm_source=rss&utm_medium=rss&utm_campaign=imperial-energy https://corvuscapital.com/portfolio/imperial-energy/#respond Fri, 05 Aug 2016 11:28:58 +0000 http://corvus-team-applewatch.com.dev/?p=60 Corvus was a founding shareholder in Imperial Energy and structured its flotation onto AIM in 2004.

The post Imperial Energy appeared first on Corvus Capital.

]]> Corvus was a founding shareholder in Imperial Energy and structured its flotation onto AIM in 2004. Imperial Energy plc is an upstream oil and gas exploration and production company focused on the Commonwealth of Independent States, in particular, the Russian Federation. The Company floated onto AIM in 2004 at 25p per share and moved to the Official List in 2007. In 2008 Imperial was acquired by ONGC Videsh Limited of India for £1.4 billion (1,125 pence per share).

The post Imperial Energy appeared first on Corvus Capital.

]]> https://corvuscapital.com/portfolio/imperial-energy/feed/ 0